Suppr超能文献

急性骨关节炎感染患儿长期肠外抗生素治疗的风险与并发症

Risks and complications of prolonged parenteral antibiotic treatment in children with acute osteoarticular infections.

作者信息

Ceroni Dimitri, Regusci Matteo, Pazos José Manuel, Saunders Catherine Tamsin, Kaelin André

机构信息

Service d'Orthopédie et de Traumatologie Pédiatrique, Hôpital des Enfants, Hôpitaux Universitaires de Genève, 6, rue Willy Donzé, 1205 Genève, Suisse.

出版信息

Acta Orthop Belg. 2003 Oct;69(5):400-4.

Abstract

This study aimed at assessing the prevalence of complications encountered during prolonged intravenous antibiotic (AB) therapy when treating acute osteoarticular (OA) infections in children. We reviewed retrospectively 60 paediatric patients treated in our department between 1988 and 1998 for acute osteoarticular infections (27 with acute haematogenous osteomyelitis, 25 with septic arthritis and 8 with septic osteoarthritis). C-reactive protein, erythrocyte sedimentation rate (ESR), and full blood count were monitored during the entire treatment. Body temperature was recorded three times per day until the fever subsided, and then daily during the remaining hospitalisation. Finally, we listed complications related to the antibiotic therapy and those linked to the presence of a venous catheter. Seventeen allergic reactions to drugs were recorded during the intravenous AB therapy. This complications occurred on average after 24.4 +/- 4.4 days of treatment. The clinical manifestations most often encountered were a delayed rise in temperature and cutaneous symptoms. Blood tests showed an isolated increase in the ESR and eosinophilia (> 1000 eosinophils/ml). Four venous catheters had to be removed, in two cases owing to their obstruction and in two cases owing to an infection. Prolonged intravenous AB therapy is not without complications due to its duration and its mode of administration. Drug allergies to AB constitute a major complication of the treatment. They may render the treatment of subsequent infections problematic and expose these patients to major allergic reactions if they accidentally encounter the molecule incriminated. Moreover, the anaesthetics required to insert a central venous catheter and the need to leave it in place for a prolonged duration constitute another source of potential complications. The duration of i.v. AB therapy could therefore be shortened if the clinical and biological evolution is favourable and the pathogen is identified.

摘要

本研究旨在评估儿童急性骨关节炎(OA)感染患者在长期静脉应用抗生素(AB)治疗期间并发症的发生率。我们回顾性分析了1988年至1998年间在我科接受治疗的60例儿童急性骨关节炎感染患者(27例急性血源性骨髓炎,25例化脓性关节炎,8例化脓性骨关节炎)。在整个治疗过程中监测C反应蛋白、红细胞沉降率(ESR)和全血细胞计数。每天记录三次体温,直至发热消退,然后在剩余住院期间每天记录一次。最后,我们列出了与抗生素治疗相关的并发症以及与静脉导管存在相关的并发症。静脉应用AB治疗期间记录到17例药物过敏反应。这些并发症平均在治疗24.4±4.4天后出现。最常出现的临床表现是体温延迟升高和皮肤症状。血液检查显示ESR单独升高和嗜酸性粒细胞增多(>1000个嗜酸性粒细胞/毫升)。4根静脉导管不得不拔除,2例是由于导管阻塞,2例是由于感染。由于长期静脉应用AB治疗的持续时间和给药方式,其并非没有并发症。对AB的药物过敏是治疗的主要并发症。它们可能使后续感染的治疗变得困难,如果这些患者意外接触到涉案分子,还会使他们面临严重的过敏反应。此外,插入中心静脉导管所需的麻醉以及需要长时间留置导管构成了另一个潜在并发症来源。因此,如果临床和生物学进展良好且病原体已确定,静脉应用AB治疗的持续时间可以缩短。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验